Home>>Histone H2A (1-20) (human, mouse, rat, bovine) (trifluoroacetate salt)

Histone H2A (1-20) (human, mouse, rat, bovine) (trifluoroacetate salt) (Synonyms: H-Ser-Gly-Arg-Gly-Lys-Gln-Gly-Gly-Lys-Ala-Arg-Ala-Lys-Ala-Lys-Thr-Arg-Ser-Ser-Arg-OH, SGRGKQGGKARAKAKTRSSR)

Catalog No.GC43826

Histone H2A (1-20) is an N-terminal peptide fragment of histone H2A that corresponds to amino acid residues 2-21 of the human histone H2A sequence.

Products are for research use only. Not for human use. We do not sell to patients.

Histone H2A (1-20) (human, mouse, rat, bovine) (trifluoroacetate salt) Chemical Structure

Size Price Stock Qty
1mg
$224.00
In stock

Tel:(909) 407-4943 Email: sales@glpbio.com

Customer Reviews

Based on customer reviews.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents Related Products

Histone H2A (1-20) is an N-terminal peptide fragment of histone H2A that corresponds to amino acid residues 2-21 of the human histone H2A sequence. Methylation of the arginine at position 3 of histone H2A by protein arginine methyltransferase 1 (PRMT1), PRMT5, or PRMT6 is associated with both transcriptional activation and repression. It is associated with DNA damage repair when methylated by PRMT7. The arginine residue at position 3 of histone H2A is also subject to citrullination by protein arginine deiminase 4 (PAD4).

Reviews

Review for Histone H2A (1-20) (human, mouse, rat, bovine) (trifluoroacetate salt)

Average Rating: 5 ★★★★★ (Based on Reviews and 34 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for Histone H2A (1-20) (human, mouse, rat, bovine) (trifluoroacetate salt)

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.